Old Web
English
Sign In
Acemap
>
authorDetail
>
B. Eam
B. Eam
Medicine
Agonist
PK/PD models
Pharmacology
Prodrug
3
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dissection of cancer therapy combinations in RTK driven tumors using zotatifin (eFT226), a potent and selective eIF4A inhibitor
2020
European Journal of Cancer
A. Gerson-Gurwitz
V K Goel
N. P. Young
B. Eam
C.R. Stumpf
M. Barrera
E Sung
J. Staunton
J. Chen
S. Fish
G.G Chiang
P A Thompson
Show All
Source
Cite
Save
Citations (1)
944 PK/PD ASSESSMENT OF A PHASE 1 HEALTHY VOLUNTEER STUDY WITH ANA773, AN ORAL PRODRUG OF A TLR7 AGONIST FOR THE TREATMENT OF HCV
2009
Journal of Hepatology
Simon P. Fletcher
Lisa A. Bauman
B. Eam
M Sergeeva
O. Khatsenko
Tim Harding
M. Rahimy
J. L. Freddo
James Appleman
Show All
Source
Cite
Save
Citations (1)
Fibrinolytic properties of activated factor XII
1998
B. Eam
G. Dooijewaard
D.C. Rijken
Show All
Source
Cite
Save
Citations (2)
1